Found: 16
Select item for more details and to access through your institution.
Proceedings from the Fourth International Symposium on σ-2 Receptors: Role in Health and Disease.
- Published in:
- eNeuro, 2020, v. 7, n. 6, p. 1, doi. 10.1523/ENEURO.0317-20.2020
- By:
- Publication type:
- Article
Discovery and Development of an Aurora Kinase Inhibitor Clinical Candidate Using an Image-Based Assay for Measuring Proliferation, Apoptosis, and DNA Content.
- Published in:
- Assay & Drug Development Technologies, 2009, v. 7, n. 2, p. 180, doi. 10.1089/adt.2007.086
- By:
- Publication type:
- Article
Henpecked to Heroism: Placing Rip Van Winkle and Francis Macomber in the American Renegade Tradition.
- Published in:
- 1998
- By:
- Publication type:
- Literary Criticism
A pilot study to evaluate the effect of CT1812 treatment on synaptic density and other biomarkers in Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13195-024-01382-2
- By:
- Publication type:
- Article
Alzheimer's protection effect of A673T mutation may be driven by lower Aβ oligomer binding affinity.
- Published in:
- Journal of Neurochemistry, 2021, v. 157, n. 4, p. 1316, doi. 10.1111/jnc.15212
- By:
- Publication type:
- Article
P4‐708: CLINICAL BIOMARKER EVIDENCE FOR TARGET ENGAGEMENT, REDUCTION OF SYNAPTIC DAMAGE AND DISEASE MODIFICATION IN ALZHEIMER'S PATIENTS TREATED WITH CT1812.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1603, doi. 10.1016/j.jalz.2019.09.072
- By:
- Publication type:
- Article
S2‐02‐03: PROGRESSION OF SYNAPTOPROTECTIVE SIGMA‐2 ANTAGONISTS INTO THE CLINIC.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P601, doi. 10.1016/j.jalz.2018.06.2608
- By:
- Publication type:
- Article
A PHASE 1 SAFETY TRIAL OF THE Aβ OLIGOMER RECEPTOR ANTAGONIST CT1812.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1570, doi. 10.1016/j.jalz.2017.07.730
- By:
- Publication type:
- Article
A TWO-PART, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 1 STUDY OF THE SAFETY AND PHARMACOKINETICS OF SINGLE AND MULTIPLE ASCENDING DOSES OF CT1812 IN HEALTHY VOLUNTEERS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P1183, doi. 10.1016/j.jalz.2016.07.127
- By:
- Publication type:
- Article
Early climbing fiber interactions with Purkinje cells in the postnatal mouse cerebellum.
- Published in:
- Journal of Comparative Neurology, 1990, v. 297, n. 1, p. 77, doi. 10.1002/cne.902970106
- By:
- Publication type:
- Article
The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2020, v. 12, n. 1, p. 1, doi. 10.1186/s13195-020-00588-4
- By:
- Publication type:
- Article
Sigma‐2 receptor antagonists rescue neuronal dysfunction induced by Parkinson's patient brain‐derived α‐synuclein.
- Published in:
- Journal of Neuroscience Research, 2021, v. 99, n. 4, p. 1161, doi. 10.1002/jnr.24782
- By:
- Publication type:
- Article
A phase 1 clinical trial of the sigma‐2 receptor complex allosteric antagonist CT1812, a novel therapeutic candidate for Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2019, v. 5, n. 1, p. 20, doi. 10.1016/j.trci.2018.11.001
- By:
- Publication type:
- Article
Individual axon morphology and thalamocortical topography in developing rat somatosensory cortex.
- Published in:
- Journal of Comparative Neurology, 1996, v. 367, n. 1, p. 36, doi. 10.1002/(SICI)1096-9861(19960325)367:1<36::AID-CNE4>3.0.CO;2-K
- By:
- Publication type:
- Article
Sigma-2 Receptors—From Basic Biology to Therapeutic Target: A Focus on Age-Related Degenerative Diseases.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 7, p. 6251, doi. 10.3390/ijms24076251
- By:
- Publication type:
- Article
Exploration of Diazaspiro Cores as Piperazine Bioisosteres in the Development of σ2 Receptor Ligands.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 15, p. 8259, doi. 10.3390/ijms23158259
- By:
- Publication type:
- Article